| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/15/2006 | CA2587940A1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 06/15/2006 | CA2587429A1 5-aminopyrazole derivatives as pesticidal compounds |
| 06/14/2006 | EP1669364A2 Methods and compositions for treating hepatitis C virus |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1668007A1 Dioxolane derivatives as cell adhesion inhibitors |
| 06/14/2006 | EP1668006A1 Quinazoline derivatives as antiproliferative agents |
| 06/14/2006 | EP1668001A1 Substituted heteroaryl benzofuran acids |
| 06/14/2006 | EP1668000A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 06/14/2006 | EP1667994A1 Quinolone antibacterial agents |
| 06/14/2006 | EP1667991A1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 06/14/2006 | EP1667990A2 New compounds |
| 06/14/2006 | EP1667988A1 Coumarins as inos inhibitors |
| 06/14/2006 | EP1667981A1 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 06/14/2006 | EP1667978A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667959A1 Biphenyloxy-acids |
| 06/14/2006 | EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 06/14/2006 | EP1587877B1 Beta-isoindigo coloring agent |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1341759B1 3-substituted oxindole beta 3 agonists |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787818A Amino cyclobutylamide modulators of chemokine receptor activity |
| 06/14/2006 | CN1259315C Antagonists of MCP-1 function and methods of use thereof |
| 06/13/2006 | US7060844 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents |
| 06/13/2006 | US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents |
| 06/13/2006 | CA2272539C Process for the stereoselective production of nitro-enamine compounds |
| 06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/08/2006 | WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors |
| 06/08/2006 | WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | WO2006060198A1 Translation lookaside buffer (tlb) access supression for intra-page program counter relative or absolute address branch instructions |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059759A1 Process for producing epoxytriazole derivative |
| 06/08/2006 | WO2006059400A1 Antibiotics fki-2140, method of producing the same and strain producing the same |
| 06/08/2006 | WO2006058993A1 Arylpiperazine derivatives and their use as ligands selective of the dopamine d3 receptor |
| 06/08/2006 | WO2006023395A3 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006011024A9 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
| 06/08/2006 | US20060122399 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 06/08/2006 | US20060122387 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
| 06/08/2006 | US20060122241 Novel macrocycles for the treatment of cancer diseases |
| 06/08/2006 | US20060122240 Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof |
| 06/08/2006 | US20060122232 4-Hydroxyfuroic acid derivatives |
| 06/08/2006 | US20060122224 Quinoline and quinoxaline compounds |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122207 Imidazol derivatives as Raf kinase inhibitors |
| 06/08/2006 | US20060122202 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122191 N-(indolethyl-)cycloamine compounds |
| 06/08/2006 | US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/08/2006 | US20060122177 Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122175 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | CA2738383A1 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/08/2006 | CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors |
| 06/07/2006 | EP1666478A1 Carbamoyl-type benzofuran derivatives |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664036A1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| 06/07/2006 | EP1664035A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 06/07/2006 | EP1664034A1 Substituted phenanthropyrans |
| 06/07/2006 | EP1664033A2 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 06/07/2006 | EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors |
| 06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 06/07/2006 | EP1664010A1 Sulfonamides antagonising n-type calcium channels |
| 06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
| 06/07/2006 | EP1663992A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 06/07/2006 | EP1663988A1 Benzyl-benzimidazolyl derivatives |
| 06/07/2006 | EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 06/07/2006 | EP1663975A1 Novel gamma secretase inhibitors |
| 06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663971A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 06/07/2006 | EP1663970A1 Matrix metalloproteinase inhibitors |
| 06/07/2006 | EP1663965A2 Thrombin receptor antagonists |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663959A1 Novel amidine compounds for treating microbial infections |
| 06/07/2006 | EP1663936A1 Biaryloxymethylarene-carboxylic acids |
| 06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
| 06/07/2006 | EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders |
| 06/07/2006 | EP1663210A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp) |
| 06/07/2006 | EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis |
| 06/07/2006 | EP1448577B1 Rhodium and iridium complexes |
| 06/07/2006 | EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |